Health
Novel CRISPR-based gene editor developed to correct mutations that cause genetic disorders – News-Medical.net
A team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore have developed a CRISPR-based gene editor, C-to-G…

A team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) have developed a CRISPR-based gene editor, C-to-G Base Editor (CGBE), to correct mutations that cause genetic disorders. Their research was published in Nature Communications on 2 March 2021.
One in seventeen people in the world suffers from some type of genetic disorder. Chances are, you or someone you know – a relative, friend, or colleague – is one of approximately 450 million…
-
Business17 hours ago
1 ASX dividend stock down 43% I’d buy right now
-
Noosa News16 hours ago
Banana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business21 hours ago
Battle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business20 hours ago
5 things to watch on the ASX 200 on Monday 7 April 2025